Z and Mmalton-1-antitrypsin deficiency-associated hepatocellular carcinoma: A genetic study

Liver International

Volumn 29, Issue 10, 2009, Pages 1593-1596

  Francalanci, Paola ^a   Santorelli, Filippo M ^a   Saccani, Simona ^b   Bonetti, Maria F ^c   Medicina, Daniela ^c   Coni, Pierpaolo ^b   Faa, Gavino ^b   Callea, Francesco ^a  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

^c 1St Departmant of Pathology   (Italy)

Author keywords

AAT globule; Genetic analysis; HCC

Indexed keywords

ALPHA 1 ANTITRYPSIN; RAUWOLFIA ALKALOID;

ADULT; ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; CASE REPORT; DISEASE ASSOCIATION; DNA SEQUENCE; FEMALE; GENETIC DISORDER; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HEPATITIS C VIRUS; HETEROZYGOSITY; HUMAN; HUMAN TISSUE; LASER MICRODISSECTION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER RESECTION; MALE; MALIGNANT TRANSFORMATION; NEEDLE BIOPSY; PERIODIC ACID SCHIFF STAIN;

ALPHA 1-ANTITRYPSIN; ALPHA 1-ANTITRYPSIN DEFICIENCY; CARCINOMA, HEPATOCELLULAR; FEMALE; GENOTYPE; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MALE; MIDDLE AGED;

EID: 73349093737     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2009.02091.x     Document Type: Article

References (19)

1. Perlmutter D.H. Alpha-1-antitrypsin deficiency: diagnosis and treatment. Clin Liver Dis 2004; 8: 839-59.
2. Eriksson S, Carlson J, Velez R. Risk of cirrhosis and primary liver cancer in alpha 1-antitrypsin deficiency. N Engl J Med 1986; 314: 736-9.
3. Crystal R.G. Alpha 1-antitrypsin deficiency, emphysema, and liver disease. Genetic basis and strategies for therapy. J Clin Invest 1990; 85: 1343-52.
4. American Thoracic Society; European Respiratory Society. American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. Am J Respir Crit Care Med 2003; 168: 818-900.
5. Sergi C, Consalez GG, Fabbretti G, et al. Immunohistochemical and genetic characterization of the M Cagliarialpha-1-antitrypsin molecule (M-like alpha-1-antitrypsin deficiency). Lab Invest 1994; 70: 130-3.
6. Propst T, Propst A, Dietze O, et al. Prevalence of hepatocellular carcinoma in alpha-1-antitrypsin deficiency. J Hepatol 1994; 21: 1006-11.
7. Rudnick DA, Perlmutter D.H. Alpha-1-antitrypsin deficiency: a new paradigm for hepatocellular carcinoma in genetic liver disease. Hepatology 2005; 42: 514-21.
8. Lucotte G, Sesboue R. Polymerase chain reaction detection of S and Z alpha-1-antitrypsin variants by duplex PCR assay. Mol Cell Probes 1999; 13: 389-91.
9. Teckman JH, Gilmore R, Perlmutter DH Role of ubiquitin in proteasomal degradation of mutant alpha(1)-antitrypsin Z in the endoplasmic reticulum. Am J Physiol Gastrointest Liver Physiol 2000; 278: G39-48.
10. Teckman JH, Perlmutter D.H. Retention of mutant alpha(1)-antitrypsin Z in endoplasmic reticulum is associated with an autophagic response. Am J Physiol Gastrointest Liver Physiol 2000; 279: G961-74.
11. Wu Y, Whitman I, Molmenti E, et al. A lag in intracellular degradation of mutant alpha 1-antitrypsin correlates with the liver disease phenotype in homozygous PiZZ alpha 1-antitrypsin deficiency. Proc Natl Acad Sci USA 1994; 91: 9014-8.
12. Janciauskiene S, Eriksson S, Callea F, et al. Differential detection of PAS-positive inclusions formed by the Z, Siiyama, and Mmalton variants of alpha1-antitrypsin. Hepatology 2004; 40: 1203-10.
13. Reid CL, Wiener GJ, Cox DW, Richter JE, Geisinger K.R. Diffuse hepatocellular dysplasia and carcinoma associated with the Mmalton variant of alpha 1-antitrypsin. Gastroenterology 1987; 93: 181-7.
14. Callea F, Brisigotti M, Fabbretti G, et al. Cirrhosis of the liver. A regenerative process. Dig Dis Sci 1991; 36: 1287-93. Review.
15. Zhou H, Ortiz-Pallardo ME, Ko Y, Fischer H.P. Is heterozygous alpha-1-antitrypsin deficiency type PIZ a risk factor for primary liver carcinoma? Cancer 2000; 88: 2668-76.
16. Rudnick DA, Liao Y, An JK, et al. Analyses of hepatocellular proliferation in a mouse model of alpha-1-antitrypsin deficiency. Hepatology 2004; 39: 1048-55.
17. Kvittingen EA, Rootwelt H, Berger R, Brandtzaeg P. Selfinduced correction of the genetic defect in tyrosinemia type I. J Clin Invest 1994; 94: 1657-61.
18. Callea F. Natural history of hepatocellular carcinoma as viewed by the pathologist. Appl Pathol 1988; 6: 105-16. Review.
19. Regev A, Guaqueta C, Molina EG, et al. Does the heterozygous state of alpha-1 antitrypsin deficiency have a role in chronic liver diseases? Interim results of a large case-control study. J Pediatr Gastroenterol Nutr 2006; 43(Suppl. 1): S30-5.